Efficacy and Safety of SGLT-2 Inhibitors in Patients with Uncontrolled or Resistant Hypertension: A Pilot Meta-Analysis of Randomized Clinical Trials [0.03%]
钠葡萄糖协同转运蛋白-2抑制剂治疗难治性高血压有效性和安全性的 meta 分析：随机临床试验的 pilot 研究
Omer Mohammed,Sun Hyeok Kim,Aditya Karthikeyan et al.
Omer Mohammed et al.
Introduction: Resistant or poorly controlled hypertension is a major contributor to cardiovascular morbidity and mortality despite contemporary multidrug regimens. ...
Efficacy and Safety of the Extemporaneous Combination Nebivolol/Amlodipine in Patients with Hypertension Uncontrolled on Monotherapy: The BOTTICELLI Study [0.03%]
固定剂量倍他乐克缓释片/氨氯地平治疗单药控制不佳高血压患者疗效与安全性：Botticelli研究
Massimo Volpe,Giovambattista Desideri,Ralf Dechend et al.
Massimo Volpe et al.
Introduction: Hypertension is the leading cause of cardiovascular disease, and its complications are preventable with blood pressure (BP)-lowering treatment. Combination treatment with 2 or more antihypertensive agents ac...
Pathophysiology and Clinical Relevance of Microvascular Remodeling in Arterial Hypertension [0.03%]
动脉高血压下的微血管重塑的病理生理及临床意义
Matteo Lemoli,Claudia Agabiti Rosei,Giacomo Buso et al.
Matteo Lemoli et al.
Long-term exposure to high blood pressure leads to systemic structural and functional changes of microcirculation, a condition named microvascular remodeling. Microvascular remodeling can be assessed in subcutaneous small resistance arterie...
Exploratory Cardiovascular Risk Modeling of Orforglipron Using the PREVENT Equations Compared with the Pooled Cohort Equations: A Post-Hoc Analysis from a Systematic Review and Meta-analysis [0.03%]
基于系统回顾和荟萃分析的探索性心血管风险建模：Orforglipron应用PREVENT方程与 pooled cohort 方程的对比——一项事后分析
Adir Alper,Adina Fagin,Aditya Karthikeyan et al.
Adir Alper et al.
Introduction: Orforglipron, an oral non-peptide GLP-1 receptor agonist, improves multiple cardiometabolic risk factors. However, prior modeling used only the 2013 Pooled Cohort Equations (PCE), which ignore body mass inde...
Pregnancy as a Window for Hypertension and Cardiovascular Prevention in Women: A Life-Course Perspective Based on the 2025 ESC Guidelines [0.03%]
基于2025年ESC指南的生命周期视角下的妊娠期女性高血压和心血管疾病预防窗口研究
Anna Vittoria Mattioli,Giulia Renda,Claudio Ferri et al.
Anna Vittoria Mattioli et al.
The 2025 European Society of Cardiology (ESC) Guidelines on cardiovascular disease in pregnancy introduce a life-course approach to cardiovascular prevention, extending risk assessment and management from preconception through the postpartu...
Orthostatic Hypotension in Hypertensive Patients Hospitalized in Italian Internal Medicine Departments: FADOI-HYP-OP Study [0.03%]
意大利内科部门住院高血压患者的直立性低血压：FADOI-HYP-OP研究
Claudio Ferri,Alberto Mazza,Dario Manfellotto et al.
Claudio Ferri et al.
Introduction: Orthostatic hypotension (OH) is defined as a decline in systolic blood pressure of at least 20 mmHg or a reduction in diastolic blood pressure of at least 10 mmHg, within the first 3 min of standing. ...
Hypertension Education, Provider, and Cardio-Cerebrovascular Symptom Awareness: 2024 Korea Community Health Survey [0.03%]
2024年韩国社区健康调查中的高血压教育、提供者和心脑血管症状意识
Nayoung Kang,Youngjae Kim,Sangah Park et al.
Nayoung Kang et al.
Introduction: Hypertension, cardiovascular disease, and cerebrovascular disease are significant public health challenges worldwide. In South Korea, heart disease and cerebrovascular disease are among the leading causes of...
Cost-Effectiveness and Budget Impact Analysis of Radiofrequency Renal Denervation for Uncontrolled and Resistant Hypertension in Italy [0.03%]
意大利顽固性高血压射频肾去神经支配的成本效益和预算影响分析
Flavio L Ribichini,Anne M Ryschon,Elisa Tacconi et al.
Flavio L Ribichini et al.
Introduction: Radiofrequency renal denervation (RF RDN) has achieved meaningful clinical benefit as an adjunct treatment for uncontrolled and resistant hypertension. ...
Effect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid Levels: A Systematic Review and Meta-analysis of Randomized Controlled Trials [0.03%]
雷塔鲁肽对血压和血脂影响的系统评价和meta分析
Luis E Simental-Mendía,Laura Jazel Barragán-Zúñiga,Valeria Reyes-Avitia
Luis E Simental-Mendía
Introduction: It has been reported that glucagon-like peptide-1 (GLP-1) agonists or dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists exert beneficial effects on blood pressure and lipid prof...
Reciprocal Relationship Between Cardiovascular Risk and Attainment of Blood Pressure and Cholesterol Targets in Users of a Mobile Health App [0.03%]
心血管风险与血压和胆固醇控制之间的互惠关系：移动医疗应用程序使用者中的纵向研究
Fabian Starnecker,Johannes Krefting,Leon Nissen et al.
Fabian Starnecker et al.
Introduction: Voluntary users of mobile health (mHealth) apps indicate an interest in lowering cardiovascular disease (CVD) risk. It is unclear by which extent blood pressure (BP) or cholesterol treatment targets are achi...